MEDICAL AUTOMATION EXPERTS


Terry Sharrer's bio:

Dr. Sharrer began as Executive Director, Medical Innovation and Transformation Institute, with the Inova Health System (Fairfax, VA) in July 2007. Formerly, he was the Curator of Health Sciences at the National Museum of American History, Smithsonian Institution, where he had worked for thirty-six years.

Terry Sharrer speaks and writes about a range of life science subjects. In 1987, he co-organized an exhibition titled "The Search for Life: Genetic Technology in the 20th Century." This show also was the inaugural exhibition for the DNA Learning Center at Cold Spring Harbor Laboratory in New York. He has done video documentaries on the Human Genome Project, the beginning of gene therapy, and the molecular biology of cancer. He holds a PhD in history from the University of Maryland, has authored some three dozen publications-including A Kind of Fate, Agricultural Change in Virginia, 1861-1920 (about the biological consequences of the Civil War and the beginning of germ theory practices, Iowa State University Press, 2000)-and currently is writing a history of molecular medicine. For outreach work, has served as Chairman of the Board of Directors of the National Foundation for Cancer Research (Bethesda, MD), board member of the Carilion Biomedical Institute (Roanoke, VA), board member, Immune Deficiency Foundation (Towson, MD), and board member, Inova Fairfax Hospital Cancer Advisory Committee (Fairfax, VA).

Currently, his public service includes: board member of the Fund for Inherited Disease Research (Bryn Mawr, PA); and Science Advisor, for the Loudoun County, VA Department of Economic Development, the Clarke County VA Education Foundation, and the Arizona Science Alliance. With his wife Patty, and sons Alex, age 13, and Nicholas, age 17, he lives in Hamilton, Loudoun County, VA.

Disclosure: G. Terry Sharrer, PhD has stock dividends in Merck and Pfizer.

Terry Sharrer's posts:

XX Chromosome Link to Autoimmune Diseases

April 2, 2024 | | Posted in Newsletter

Xist ribonucleoproteins promote female sex-biased autoimmunity
From Stanford University researchers: “Xist long non-coding RNA (lncRNA) is expressed only in females to [MORE]

Functioning Bladder from Baboon Bone Marrow Cells

April 2, 2024 | | Posted in Newsletter

Functional bladder tissue regenerated using bone marrow cells
“Scientists from Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie [MORE]

Automated Single-Cell Multiomics

April 2, 2024 | | Posted in Newsletter

 
BD, Hamilton collaborate to standardize single-cell multiomics experiments using robotics
“BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical [MORE]

New Material Stops Bleeding in People Taking Blood Thinners

April 2, 2024 | | Posted in Newsletter

Bioengineered material developed to rapidly stop bleeding in patients on blood thinners
“To improve strategies for reducing blood loss, a team [MORE]

Microfluidics Chip Determines Effectiveness of Chemoradiation in NSCLC

April 2, 2024 | | Posted in Newsletter

Is lung cancer treatment working? This chip can tell from a blood draw
“Using an ultrasensitive graphene oxide microfluidic chip nanotechnology [MORE]

Magnetized Neurons in Treating PD

April 2, 2024 | | Posted in Newsletter

Using magnetized neurons to treat Parkinson’s disease symptoms
“Researchers [at Yonsei University in Seoul], report in ACS’ Nano Letters a new [MORE]

Retinal Optical Coherence Tomography Images Identify Links between Ocular and Systemic Health

April 2, 2024 | | Posted in Newsletter

Eyes provide window into many diseases
“Researchers {at the Massachusetts Eye and Ear Clinic and Harvard University] have found that the [MORE]

Priming Liquid Biopsies

March 26, 2024 | | Posted in Newsletter

Novel priming strategy boosts liquid biopsy sensitivity
“A team of researchers from MIT and the Broad Institute of MIT and Harvard [MORE]

Nano-Carriers for Oral Delivery of Insulin

March 26, 2024 | | Posted in Newsletter

Insulin delivered via nano-carriers paves the way for oral diabetes treatment
“Australian and Norwegian researchers report they have developed a new [MORE]

Electrically Triggered Microneedle Patch

March 26, 2024 | | Posted in Newsletter

Digital automation of transdermal drug delivery with high spatiotemporal resolution
“Here, we report a spatiotemporal on-demand patch (SOP) that integrates drug-loaded [MORE]

Universal Pattern of Brain Wave Frequencies

March 26, 2024 | | Posted in Newsletter

Study reveals a universal pattern of brain wave frequencies
“Throughout the brain’s cortex, neurons are arranged in six distinctive layers, which [MORE]

Clinical Success for Gene Editing, but at a Price None Could Afford

March 26, 2024 | | Posted in Newsletter

The first gene-editing treatment for Sickle Cell
“Many CRISPR treatments are in trials, but in 2022, Vertex Pharmaceuticals, based in Boston, [MORE]

AI Analysis of Tumor Genetics Predicts Drug Response

March 26, 2024 | | Posted in Newsletter

AI uses tumor genetics for prediction of treatment response
“Scientists at the University of California (UC) San Diego School of Medicine [MORE]

Successful Gene Therapy for Congenital Deafness

March 26, 2024 | | Posted in Newsletter

A medical first- Gene therapy allows boy to hear
“An 11-year-old boy recently became the first person in the U.S. to [MORE]